- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Metadherin Antibody / MTDH Antibody recognizes metadherin (MTDH), also known as astrocyte elevated gene-1 (AEG-1) and LYRIC, a multifunctional protein that regulates tumor progression, metastasis, cell survival, and inflammatory signaling. MTDH is broadly expressed in normal tissues but is frequently overexpressed in numerous malignancies, including breast, colorectal, lung, liver, prostate, ovarian, and brain cancers. Elevated metadherin expression has been consistently associated with aggressive tumor behavior, metastatic dissemination, therapeutic resistance, and poor clinical outcome, making it an important biomarker and therapeutic target in oncology.
MTDH participates in multiple signaling pathways that regulate proliferation, apoptosis, epithelial-mesenchymal transition, angiogenesis, invasion, and immune responses. It interacts with components of the nuclear factor kappa B, phosphoinositide 3-kinase/AKT, Wnt/beta-catenin, mitogen-activated protein kinase, and signal transducer and activator of transcription pathways, coordinating transcriptional programs that promote tumor cell survival and metastatic progression. Metadherin also contributes to chemoresistance by enhancing DNA damage repair, suppressing apoptosis, and supporting cancer stem cell maintenance, making it an active focus of translational cancer research.
Beyond oncology, MTDH has important functions in neurobiology, antiviral immunity, inflammation, and tissue homeostasis. Originally identified as an astrocyte-induced gene, metadherin is now recognized as a regulator of interactions between tumor cells and the surrounding microenvironment, including extracellular matrix remodeling, endothelial activation, and immune cell recruitment. Additional studies have implicated MTDH in RNA metabolism, stress responses, and intracellular trafficking, highlighting its diverse biological functions across multiple tissues.
Because of its central role in tumor progression and multiple oncogenic signaling pathways, MTDH continues to be investigated as both a prognostic biomarker and a potential therapeutic target. A Metadherin Antibody is a valuable research tool for investigating MTDH, tumor progression, metastasis, oncogenic signaling, chemoresistance, and cancer biology.
Explore additional reagents for studies of tumor progression, metastasis, and oncogenic signaling on our Cancer Marker Antibodies page.
The stated application concentrations are suggested starting amounts. Titration of the Metadherin Antibody / MTDH Antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Human partial recombinant protein (AA 101-270) was used as the immunogen for this Metadherin Antibody.
After reconstitution, the Metadherin Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Metadherin antibody, MTDH antibody, Astrocyte Elevated Gene-1 antibody, AEG-1 antibody, LYRIC antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.